Evidence map›Paper›PMID 32071361›Full record

ArticleScientific reports2020

Seroprevalences of autoantibodies and anti-infectious antibodies among Ghana's healthy population.

Itai Katz, F De Luca, Bartholomew Dzudzor, Baffour Kyei Sarpong, Beatrice Osei-Appiah, Danielle Azoulay, Daphna Katz, Dzifa Dey, Boris Gilburd, Howard Amital and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Low Prevalence of HSV-1 andDiagnostics (Basel, Switzerland) · 2023
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 6 countries.

Itai Katz *Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel.
F De Luca *Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel.
Bartholomew DzudzorDepartment of Medical Biochemistry, University of Ghana School of Medicine and Dentistry, College of Health Sciences, Korle-Bu, Accra, Ghana.
Baffour Kyei SarpongDepartment of Medical Biochemistry, University of Ghana School of Medicine and Dentistry, College of Health Sciences, Korle-Bu, Accra, Ghana.
Beatrice Osei-AppiahDepartment of Medical Biochemistry, University of Ghana School of Medicine and Dentistry, College of Health Sciences, Korle-Bu, Accra, Ghana.
Danielle AzoulayZabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel.
Daphna KatzZabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel.
Dzifa DeyDepartment of Medicine and Therapeutics, University of Ghana School of Medicine and Dentistry, College of Health Sciences, Korle-Bu, Accra, Ghana.
Boris GilburdZabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel.
Howard AmitalZabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel.
Sandro VentoFaculty of Medicine, University of Puthisastra, Phnom Penh, Cambodia.
Yehuda ShoenfeldZabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel.
Ora ShovmanZabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel. orashovman@walla.com.
Sheba Medical Center · ILKorle Bu Teaching Hospital · GHTel Aviv University · ILUniversity of Ghana · GHAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITUniversity of Puthisastra · KHUniversity of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoantibodies, which are antibodies that target self-epitopes, have considerable diagnostic, prognostic and predictive value in specific autoimmune diseases. Various infectious agents have been linked via numerous mechanisms to the formation of different autoantibodies. Therefore, estimating the prevalence of autoantibodies and anti-infectious antibodies in different populations is of high importance. Different genetic and environmental pressures, such as these found in Ghana's different geographical provinces, may affect the prevalence of autoantibodies. In this study, we assessed the seroprevalence of a diverse panel of autoantibodies and anti-infectious antibodies among the healthy Ghanaian population and investigated possible environmental and genetic predispositions for autoantibodies and autoimmunity. The sera of 406 healthy individuals were obtained from Greater Accra, Upper West, Eastern and Volta regions. Multiplexed assay and chemiluminescent immunoassay techniques were utilized to assess the presence of a panel of autoantibodies and anti-infectious antibodies. We found a high prevalence of anti-HSV-1 IgG (91-100%), anti-EBNA IgG (81-93%) and anti-EBV-VCA IgG (97-100%) antibodies. The prevalence of ANA (at least one of: anti-dsDNA; anti-chromatin; anti-ribosomal-P; anti-Ro/SSA; anti-La/SSB; anti-centromere B; anti-Sm; anti-Sm/RNP; anti-Scl-70; anti-Jo1; anti-DFS70) was estimated at 14%. An inverse association between anti-HSV-2 antibodies and ANA (p = 0.044; adjusted OR = 0.398; CI [0.162-0.975]) was found, after adjusting for differences in gender, age, and familial history of autoimmune diseases. A trend towards reduced seroprevalence of anti-dsDNA antibodies among subjects who were positive for anti-HSV-2 antibodies was also noted (p = 0.1). In conclusion, the inverse association between anti-HSV-2 antibodies and ANA positivity suggests a possible protective role of HSV-2 infection against autoimmunity.

Indexed as

AdolescentAdultAgedAntibodies, AntinuclearAntibodies, AntiphospholipidAntibodies, ViralAutoimmune DiseasesEpstein-Barr Virus InfectionsFemaleGhanaHerpes SimplexHumansMaleMiddle AgedSeroepidemiologic StudiesYoung AdultAntibodies, AntinuclearAntibodies, AntiphospholipidAntibodies, Viral

Identifiers

PMID32071361
PMCPMC7028981
OpenAlexW3008514324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.